EVA RAMIREZ: Open Payments
NPI 1730538281 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 11 payments from 10 companies in 2025. Trend: 2023 $920 · 2024 $593 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $131 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| Dexcom, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| GENZYME CORPORATION | 1 | $119 |
| Novo Nordisk Inc | 1 | $105 |
| Neurocrine BioSciences, Inc. | 1 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $76 |
| Boston Scientific Corporation | 2 | $40 |
| Abbott Laboratories | 1 | $25 |
Products named: INCEPTIV, CAPLYTA, DEXCOM G7 GSS (161), FASENRA, Wegovy, Kerendia, PROCLAIM, WaveWriter Alpha Prime 16.
Industry payments across TX — which companies pay providers there.
